ambamustine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellesi, G; Castoldi, G; Gherlinzoni, F; Lanza, F; Mangoni, L; Mazza, P; Rizzoli, V; Rossi Ferrini, PL; Tura, S; Zinzani, PL | 1 |
| Cavo, M; Galieni, P; Gherlinzoni, F; Lemoli, RM; Mazza, P; Poletti, G; Tassi, C; Tura, S; Visani, G; Zinzani, PL | 1 |
3 other study(ies) available for ambamustine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Ambamustine. PTT119.
Topics: Alkylating Agents; Animals; Carcinoma, Small Cell; Drugs, Investigational; Humans; Injections, Intravenous; Italy; Lymphoma, Non-Hodgkin; Mice; Nitrogen Mustard Compounds; Rhabdomyosarcoma | 2003 |
Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Nitrogen Mustard Compounds; Thrombocytopenia | 1990 |
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Agents; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrogen Mustard Compounds | 1989 |